Supriya Lifescience has informed that the Board of Directors of the Company at their Meeting held on January 24, 2025 has considered and approved the Unaudited Financial Results for the quarter and nine months ended December 31, 2024. The company has attached the Press Release with regard to the Unaudited Financial Results of the Company for the quarter and nine months ended December 31, 2024.
The above information is a part of company’s filings submitted to BSE.